The independent source for health policy research, polling, and news.
761 - 780 of 3,682 Results
The advocacy group American Commitment said empowering Medicare to negotiate drug prices would raid it of billions of dollars. Drug pricing experts say that that鈥檚 not the case and that such policies would instead reduce costs for the Medicare program and seniors.
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
Amparo and Victor Rios began searching for answers about their son鈥檚 development when he didn鈥檛 hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.
California Gov. Gavin Newsom signed a bill last month that authorizes a statewide Medicaid contract for HMO giant Kaiser Permanente. But details still need to be worked out in a memorandum of understanding.
KHN gives readers a chance to comment on a recent batch of stories.
A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.
Even before the Supreme Court struck down the constitutional right to abortion, insurance coverage for the service varied widely. Now it鈥檚 become even more complex, with additional changes and court challenges to come.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Medical breakthroughs mean cancer is less likely to kill, but survival can come at an extraordinary cost as patients drain savings, declare bankruptcy, or lose their homes, a KHN-NPR investigation finds.
Even a decade in, the Affordable Care Act鈥檚 recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
Work-based benefits may expand access to abortion for people who live in areas where the service is unavailable, but experts warn that claiming benefits could create a paper trail for law enforcement officials to follow.
Medical bills can add stress to the already stressful experience of dealing with a medical crisis. And if you can鈥檛 pay those bills, they can linger, wreaking havoc on your financial goals and credit. Here鈥檚 how to protect yourself.
The Government Accountability Office and the Health and Human Services inspector general鈥檚 office say seniors enrolled in the program are suffering and taxpayers are getting bilked for billions of dollars a year.
Whether a simple operation is performed under the auspices of a hospital or at an independent surgery center can make a huge difference in cost.
KHN gives readers a chance to comment on a recent batch of stories.
The FDA is using its power to regulate tobacco products 鈥 ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.
Hispanic residents have long been among the least likely to have health insurance 鈥 in Colorado and across the country 鈥 in part because of unauthorized immigrants. The state is expanding coverage to some of them, although the change runs up against lingering fears about the use of public benefits.
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person鈥檚 stomach, to help people eat less. Results vary widely but are modest on average.
Medical debt is most prevalent in the Southeast, where states have not expanded Medicaid and have few consumer protection laws. Now, North Carolina is considering two bills that could change that, making the state a leader in protecting patients from high medical bills.
漏 2026 麻豆女优